NRX Pharmaceuticals NRXP
NASDAQ NRXP
$3.56 +0.05 (+1.42%)
At close: Aug 21, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Interest Expenses (2017 - 2026)

NRX Pharmaceuticals (NRXP) posted quarterly Interest Expenses of $233000.0 for Q1 2026, down 21.55% quarter-over-quarter from $297000.0 in Q4 2025.

NRX Pharmaceuticals (NRXP) Interest Expenses (2017 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has reported Interest Expenses for 9 consecutive years, with $233000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Expenses changed N/A year-over-year to $233000.0; the TTM figure through Mar 2026 stood at $530000.0 (up 130.43% YoY), while the FY2025 annual figure was $51.2 million, up 3.09% from the prior year.
  • Interest Expenses fell to $233000.0 in Q1 2026 per NRXP's latest filing, from $297000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2.5 million in Q4 2022 and bottomed at -$144000.0 in Q4 2024.
  • Historically, Interest Expenses has averaged $447000.0 across 5 years, with a median of $233000.0 in 2026.
  • Annual changes were most pronounced in 2022 — Interest Expenses surged 127350.0% — and 2024, when it sank 177.84%.
  • NRX Pharmaceuticals' Interest Expenses stood at $2.5 million in 2022, then slumped by 92.74% to $185000.0 in 2023, then tumbled by 177.84% to -$144000.0 in 2024, then jumped by 306.25% to $297000.0 in 2025, then dropped by 21.55% to $233000.0 in 2026.
  • Business Quant data shows NRXP's Interest Expenses at $233000.0 in Q1 2026, $297000.0 in Q4 2025, and $189000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 82.05 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -4.89 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 20.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 93.62 Mn
10 NRX Pharmaceuticals 132.53 Mn 105.83 Mn 426,000.00 240,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 233,000.00
Mar 31, 2026 233,000.00
Dec 31, 2025 297,000.00
Dec 31, 2025 297,000.00
Sep 30, 2025 189,000.00
Sep 30, 2025 189,000.00
Dec 31, 2024 -144,000.00
Dec 31, 2024 -144,000.00
Mar 31, 2024 374,000.00
Mar 31, 2024 374,000.00
Dec 31, 2023 185,000.00
Dec 31, 2023 185,000.00
Sep 30, 2023 500,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 46,000.00
Jun 30, 2023 46,000.00
Mar 31, 2023 124,000.00
Mar 31, 2023 124,000.00
Dec 31, 2022 2.55 Mn
Dec 31, 2022 2.55 Mn